Document Detail

On the need for erythropoietin treatment in dialysis patients. A Copenhagen City Dialysis Unit study.
MedLine Citation:
PMID:  2228289     Owner:  NLM     Status:  MEDLINE    
We evaluated the need for erythropoietin (EPO) treatment in 134 end-stage renal disease patients assuming a level of hemoglobin below 6 mmol/l (9.6 g/dl) as indication for treatment. 91 patients (68%) fulfilled this criterion. Absolute contraindications in 2 patients were previous thrombotic encephalopathy and refusal of treatment. Relative contraindications due to cardiac disease were found in 3 patients. In 15 patients additional treatment was required because of hypertension (5) or deficiency states (10). The implications of elevated serum PTH and aluminum overload are discussed.
D Stenver; B Nielsen
Related Documents :
19587499 - Effect of dialysate temperature on hemodynamic stability among hemodialysis patients.
884909 - Dialysis in the treatment of renal failure in patients with liver disease.
11053589 - Unraveling the realities of vascular access: the network 11 experience.
8355729 - Are nerve conduction studies useful for monitoring the adequacy of renal dialysis?
3627319 - Erythrocyte sodium transport in normotensive and hypertensive patients on chronic hemod...
12552509 - Decreased survival among sedentary patients undergoing dialysis: results from the dialy...
3554839 - Clinical manifestations of lyme disease.
10451139 - Cisatracurium in a myasthenic patient undergoing thymectomy.
10852689 - The safety of intravenous iron dextran (dexferrum) during hemodialysis in patients with...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The International journal of artificial organs     Volume:  13     ISSN:  0391-3988     ISO Abbreviation:  Int J Artif Organs     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-12-11     Completed Date:  1990-12-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7802649     Medline TA:  Int J Artif Organs     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  474-6     Citation Subset:  IM    
Department of Nephrology, Hvidovre Hospital, University of Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / drug therapy*,  epidemiology,  etiology
Denmark / epidemiology
Erythropoietin / contraindications,  therapeutic use*
Hemodialysis Units, Hospital
Kidney Failure, Chronic / complications*,  therapy
Middle Aged
Recombinant Proteins / therapeutic use
Risk Factors
Reg. No./Substance:
0/Recombinant Proteins; 11096-26-7/Erythropoietin
Comment In:
Int J Artif Organs. 1990 Aug;13(8):472-3   [PMID:  2228288 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Attitudes toward retirement in an Israeli cohort.
Next Document:  Magnetic resonance imaging of the bone marrow following treatment with recombinant human erythropoie...